Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Eur J Pharm Biopharm. 2021 Mar 19;163:23–37. doi: 10.1016/j.ejpb.2021.03.007

Figure 2.

Figure 2

Comparison of morphology for the adjuvant-only SD-TG formulation, antigen-containing SD-TGI formulation, spray-dried trehalose and the lyophlized vaccine. External morphology of all spray-dried powders shows similar spherical, polydisperse particles that are not fused. Interior structure of the lyophilized vaccine and the spray-dried particles shows similar voids left by the encapsulated emulsion droplets. Scales are provided on the respective images.